US Stock MarketDetailed Quotes
SYRA Syra Health
- 0.439
- +0.012+2.69%
Close Nov 27 16:00 ET
7.59MMarket Cap-1747P/E (TTM)
0.480High0.398Low1.43MVolume0.398Open0.427Pre Close626.74KTurnover22.08%Turnover RatioLossP/E (Static)17.31MShares8.37052wk High2.28P/B2.85MFloat Cap0.34452wk Low--Dividend TTM6.49MShs Float8.370Historical High--Div YieldTTM19.18%Amplitude0.344Historical Low0.437Avg Price1Lot Size
Syra Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -11.93%-413.3K | -155.79%-1.5M | -1,676.99%-800.75K | -22.95%-2.76M | -43.85%-1.76M | 6.80%-369.26K | -35.31%-587.7K | 76.55%-45.06K | -2,444.32%-2.24M | -1.22M |
| Net income from continuing operations | -17.82%-417.54K | -73.18%-1.39M | -84.13%-1.45M | -38.72%-2.94M | -62.46%-995.28K | 0.04%-354.38K | -27.95%-802.8K | -50.10%-785.89K | -64,478.20%-2.12M | ---612.63K |
| Depreciation and amortization | 106.69%25.54K | 41.33%17.37K | 6.65%12.55K | 228.45%48.77K | 22.87%12.36K | 218.48%12.36K | 1,962.58%12.29K | 3,634.29%11.76K | 7,073.43%14.85K | --10.06K |
| Other non cash items | 21.03%36.9K | 68.71%50.7K | 69.62%50.25K | -80.46%121.09K | -6.74%30.93K | -6.90%30.49K | -65.68%30.05K | -93.65%29.62K | 2,173.15%619.64K | --33.16K |
| Change In working capital | 1.03%-58.2K | -220.93%-195.43K | -18.44%569.37K | 96.93%-23.42K | -26.09%-824.29K | 25.98%-58.81K | 54.03%161.61K | 617.03%698.08K | -579.18%-763.3K | ---653.75K |
| -Change in receivables | 93.31%-42.94K | 76.10%-13.7K | -66.07%283.44K | 88.29%-110.16K | 57.86%-246.49K | -432.96%-641.82K | 84.19%-57.31K | 549.93%835.46K | -260.85%-940.47K | ---584.99K |
| -Change in payables and accrued expense | -134.70%-151.79K | -339.58%-290.93K | 6,510.82%303.3K | -99.00%4.72K | -1,179.45%-549.37K | 247.86%437.39K | -78.49%121.43K | -103.08%-4.73K | 140.37%473.53K | --50.89K |
| -Change in other current assets | 296.13%136.53K | 10.58%141.03K | 107.67%7.9K | 201.15%203.11K | 259.34%144.13K | -34.22%34.47K | 273.56%127.54K | -15.43%-103.03K | -833.77%-200.8K | ---90.46K |
| -Change in other current liabilities | --0 | -5.90%-31.83K | -5.90%-31.37K | -26.71%-121.09K | -5.91%-30.93K | -5.91%-30.49K | -27.08%-30.05K | -112.72%-29.62K | -250.57%-95.56K | ---29.2K |
| -Change in other working capital | --0 | --0 | --6.11K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -11.93%-413.3K | -155.79%-1.5M | -1,676.99%-800.75K | -22.95%-2.76M | -43.85%-1.76M | 6.80%-369.26K | -35.31%-587.7K | 76.55%-45.06K | -2,444.32%-2.24M | ---1.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 1.79%-5.49K | 41.83%-5.62K | 87.42%-15.25K | 0 | 0 | 54.93%-5.59K | -9.66K | -1,828.13%-121.26K | -44.9K |
| Net PPE purchase and sale | --0 | 1.79%-5.49K | 41.83%-5.62K | 87.42%-15.25K | --0 | --0 | 54.93%-5.59K | ---9.66K | -1,828.13%-121.26K | ---44.9K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 1.79%-5.49K | 41.83%-5.62K | 87.42%-15.25K | --0 | --0 | 54.93%-5.59K | ---9.66K | -1,828.13%-121.26K | ---44.9K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 332.24%1.52M | -504.57%-134.85K | 17.98%764.25K | 166.72%6.05M | 734.96%5.02M | 234.58%350.82K | -94.72%33.33K | -30.48%647.79K | 1,084.68%2.27M | 601.12K |
| Net issuance payments of debt | ---102.61K | -166.90%-134.85K | -110.69%-85.88K | -29.56%518.76K | -164.73%-485.85K | --0 | 175.21%201.56K | 363.33%803.05K | 245,391.67%736.48K | --750.55K |
| Net common stock issuance | ---- | ---- | ---- | 129.59%5.33M | --5.33M | ---- | ---- | ---- | --2.32M | --0 |
| Proceeds from stock option exercised by employees | ---- | --0 | --850.13K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | 125.31%200.01K | 215.55%172.67K | 334.77%350.82K | 32.70%-168.22K | 35.71%-155.26K | -513.35%-790.32K | ---149.43K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 332.24%1.52M | -504.57%-134.85K | 17.98%764.25K | 166.72%6.05M | 734.96%5.02M | 234.58%350.82K | -94.72%33.33K | -30.48%647.79K | 1,084.68%2.27M | --601.12K |
| Net cash flow | ||||||||||
| Beginning cash position | 4,274.20%1.59M | 442.91%3.24M | 97,988.37%3.28M | -96.66%3.34K | -97.31%18.01K | -96.44%36.45K | -28.97%596.41K | -96.66%3.34K | 3,233.73%100.01K | --668.53K |
| Current changes in cash | 6,082.47%1.1M | -193.52%-1.64M | -107.10%-42.12K | 3,489.67%3.28M | 590.40%3.26M | 94.81%-18.44K | -404.10%-559.96K | -19.82%593.07K | -199.65%-96.67K | ---665.19K |
| End cash Position | 14,877.56%2.7M | 4,274.20%1.59M | 442.91%3.24M | 97,988.37%3.28M | 97,988.37%3.28M | -97.31%18.01K | -96.44%36.45K | -28.97%596.41K | -96.66%3.34K | --3.34K |
| Free cash flow | -11.93%-413.3K | -154.30%-1.51M | -1,373.59%-806.36K | -17.29%-2.77M | -38.75%-1.76M | 19.75%-369.26K | -32.81%-593.29K | 71.52%-54.72K | -2,403.31%-2.37M | ---1.27M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
